It was recently observed that clients who had elevated miR-629 levels usually had poor prognoses, and that high miR-629 levels in NSCLC accelerated NSCLC growth by blocking the transcription factor FOXO1 (22). Here, FOXO1 is linked to non-small cell lung carcinoma.